Blog

Biology meets commercial thinking.

Frameworks, patterns, and ideas for life sciences decision makers.

The Price Tag: A Titration

Pricing: like a titration in the flask, but with many variables

Have you ever faced the question of putting a price on your science? Cost plus margin was right. I still lost the contract.

Read →
Scientists adopt trust signals first

Scientists adopt trust signals first. The technology comes second.

I surveyed 213 life sciences professionals for my MBA dissertation. The strongest predictor of ML adoption wasn't capability. It was trust.

Read →
The obligate mutualist

The obligate mutualist: customer concentration as coevolution

Biology calls it obligate mutualism. Business calls it your best client. Both can end you.

Read →
Augmented Product Model

The science works. The data is solid. But your audience is not convinced to leap.

Having a great scientific idea that doesn't stick with the market? The problem is rarely in the lab. Kotler's Augmented Product Model can explain why.

Read →
Innovation Ambition Matrix

The Ambition Matrix: A strategic lens for life sciences innovation portfolios

As scientists, we were trained to transform the world. What nobody told us: transformation is the result of endless incremental steps. This matrix helps.

Read →
The Ansoff Matrix

The Ansoff Matrix: A handy compass for Life Sciences Innovation

My favourite framework for rapid R&D assessment. When scientists present new ideas: are we innovating on product, market, or both?

Read →
The Idle Valley Problem

The Idle Valley: The hidden cost when R&D and product management fall out of sync

There's a timing problem between life sciences R&D cycles and product management. I wrote about it.

Read →

Let's close the gap.

Projects closed. Frameworks deployed. Products launched.

Ready to move forward? →